AAAAAA
Results: 51-75/7226
Authors:
STROJAN P
BUDIHNA M
SMID L
VRHOVEC I
SKRK J
Citation: P. Strojan et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN TISSUE AND SERUM OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA PATIENTS, European journal of cancer, 34(8), 1998, pp. 1193-1197
Authors:
RAEDLE J
OREMEK G
TRUSCHNOWITSCH M
LORENZ M
ROTH WK
CASPARY WF
ZEUZEM S
Citation: J. Raedle et al., CLINICAL-EVALUATION OF AUTOANTIBODIES TO P53 PROTEIN IN PATIENTS WITHCHRONIC LIVER-DISEASE AND HEPATOCELLULAR-CARCINOMA, European journal of cancer, 34(8), 1998, pp. 1198-1203
Authors:
BOWER M
RUSTIN GJS
NEWLANDS ES
HOLDEN L
SHORT D
FOSKETT M
BAGSHAWE KD
Citation: M. Bower et al., CHEMOTHERAPY FOR GESTATIONAL TROPHOBLASTIC TUMORS HASTENS MENOPAUSE BY 3 YEARS, European journal of cancer, 34(8), 1998, pp. 1204-1207
Authors:
LORUSSO V
POLLERA CF
ANTIMI M
LUPORINI G
GRIDELLI C
FRASSINETI GL
OLIVA C
PACINI M
DELENA M
Citation: V. Lorusso et al., A PHASE-II STUDY OF GEMCITABINE IN PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT PREVIOUSLY TREATED WITH PLATINUM, European journal of cancer, 34(8), 1998, pp. 1208-1212
Authors:
SERSA G
STABUC B
CEMAZAR M
JANCAR B
MIKLAVCIC D
RUDOLF Z
Citation: G. Sersa et al., ELECTROCHEMOTHERAPY WITH CISPLATIN - POTENTIATION OF LOCAL CISPLATIN ANTITUMOR EFFECTIVENESS BY APPLICATION OF ELECTRIC PULSES IN CANCER-PATIENTS, European journal of cancer, 34(8), 1998, pp. 1213-1218
Authors:
TORNESELLO A
PICIACCHIA D
MASTRANGELO S
LASORELLA A
MASTRANGELO R
Citation: A. Tornesello et al., VENOOCCLUSIVE DISEASE OF THE LIVER IN RIGHT-SIDED WILMS-TUMORS, European journal of cancer, 34(8), 1998, pp. 1220-1223
Authors:
ARNDT CAS
NASCIMENTO AG
SCHROEDER G
SCHOMBERG PJ
NEGLIA JP
SENCER SF
SILBERMAN TL
MOERTEL CL
TILLISCH JK
MISER JS
Citation: Cas. Arndt et al., TREATMENT OF INTERMEDIATE RISK RHABDOMYOSARCOMA AND UNDIFFERENTIATED SARCOMA WITH ALTERNATING CYCLES OF VINCRISTINE DOXORUBICIN/CYCLOPHOSPHAMIDE AND ETOPOSIDE/IFOSFAMIDE/, European journal of cancer, 34(8), 1998, pp. 1224-1229
Authors:
SVARE EI
KJAER SK
SMITS HL
POLL P
TJONGAHUNG SP
TERSCHEGGET J
Citation: Ei. Svare et al., RISK-FACTORS FOR HPV DETECTION IN ARCHIVAL PAP-SMEARS - A POPULATION-BASED STUDY FROM GREENLAND AND DENMARK, European journal of cancer, 34(8), 1998, pp. 1230-1234
Authors:
KUIJPENS JL
HANSEN B
HAMMING JF
RIBOT JG
HAAK HR
COEBERGH JWW
Citation: Jl. Kuijpens et al., TRENDS IN TREATMENT AND LONG-TERM SURVIVAL OF THYROID-CANCER IN SOUTHEASTERN NETHERLANDS, 1960-1992, European journal of cancer, 34(8), 1998, pp. 1235-1241
Authors:
BISOFFI M
CHAKERIAN AE
FORE ML
BRYANT JE
HERNANDEZ JP
MOYZIS RK
GRIFFITH JK
Citation: M. Bisoffi et al., INHIBITION OF HUMAN TELOMERASE BY A RETROVIRUS EXPRESSING TELOMERIC ANTISENSE RNA, European journal of cancer, 34(8), 1998, pp. 1242-1249
Authors:
DUFFY CP
ELLIOTT CJ
OCONNOR RA
HEENAN MM
COYLE S
CLEARY IM
KAVANAGH K
VERHAEGEN S
OLOUGHLIN CM
NICAMHLAOIBH R
CLYNES M
Citation: Cp. Duffy et al., ENHANCEMENT OF CHEMOTHERAPEUTIC DRUG TOXICITY TO HUMAN TUMOR-CELLS IN-VITRO BY A SUBSET OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS), European journal of cancer, 34(8), 1998, pp. 1250-1259
Authors:
NOGUCHI K
MURATA T
CHOCHUNG YS
Citation: K. Noguchi et al., 8-CHLOROADENOSINE 3',5'-MONOPHOSPHATE (8-CL-CAMP) SELECTIVELY ELIMINATES PROTEIN-KINASE-A TYPE-I TO INDUCE GROWTH-INHIBITION IN C-RAS-TRANSFORMED FIBROBLASTS, European journal of cancer, 34(8), 1998, pp. 1260-1267
Authors:
POPESCU RA
LOHRI A
DEKANT E
THIEDE C
REUTER J
HERRMANN R
ROCHLITZ CF
Citation: Ra. Popescu et al., BCL-2 EXPRESSION IS RECIPROCAL TO P53 AND C-MYC EXPRESSION IN METASTATIC HUMAN COLORECTAL-CANCER, European journal of cancer, 34(8), 1998, pp. 1268-1273
Authors:
MIWA M
URA M
NISHIDA M
SAWADA N
ISHIKAWA T
MORI K
SHIMMA N
UMEDA I
ISHITSUKA H
Citation: M. Miwa et al., DESIGN OF A NOVEL ORAL FLUOROPYRIMIDINE CARBAMATE, CAPECITABINE, WHICH GENERATES 5-FLUOROURACIL SELECTIVELY IN TUMORS BY ENZYMES CONCENTRATED IN HUMAN LIVER AND CANCER-TISSUE, European journal of cancer, 34(8), 1998, pp. 1274-1281
Authors:
PANG JH
CAO Z
JOSEPH WR
BAGULEY BC
CHING LM
Citation: Jh. Pang et al., ANTITUMOR-ACTIVITY OF THE NOVEL IMMUNE MODULATOR 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA) IN MICE LACKING THE INTERFERON-GAMMA RECEPTOR, European journal of cancer, 34(8), 1998, pp. 1282-1289
Authors:
STRUMBERG D
ERHARD J
HARSTRICK A
KLAASSEN U
MULLER C
EBERHARDT W
WILKE H
SEEBER S
Citation: D. Strumberg et al., PHASE-I STUDY OF A WEEKLY 1 H INFUSION OF PACLITAXEL IN PATIENTS WITHUNRESECTABLE HEPATOCELLULAR-CARCINOMA, European journal of cancer, 34(8), 1998, pp. 1290-1292
Authors:
WYMENGA ANM
DEVRIES EGE
LEIJSMA MK
KEMA IP
KLEIBEUKER JH
Citation: Anm. Wymenga et al., EFFECTS OF ONDANSETRON ON GASTROINTESTINAL SYMPTOMS IN CARCINOID-SYNDROME, European journal of cancer, 34(8), 1998, pp. 1293-1294
Authors:
VASSILOMANOLAKIS M
TSOUSSIS S
EFREMIDIS A
Citation: M. Vassilomanolakis et al., LONG-LASTING, GRADE-IV, ORTHOSTATIC HYPOTENSION AFTER A SINGLE-CYCLE COMBINATION CHEMOTHERAPY WITH PACLITAXEL AND CISPLATIN, European journal of cancer, 34(8), 1998, pp. 1295-1295
Authors:
MERIMSKY O
MELLER I
KOLLENDER Y
INBAR M
Citation: O. Merimsky et al., PALLIATIVE EFFECT OF GEMCITABINE IN OSTEOSARCOMA RESISTANT TO STANDARD CHEMOTHERAPY, European journal of cancer, 34(8), 1998, pp. 1296-1297
Authors:
TOURNIGAND C
MAINDRAULTGOEBEL F
LOUVET C
DEGRAMONT A
KRULIK M
Citation: C. Tournigand et al., SEVERE ANAPHYLACTIC REACTIONS TO OXALIPLATIN, European journal of cancer, 34(8), 1998, pp. 1297-1298
Authors:
BENOY I
VERMEULEN P
WUYTS H
DIRIX L
Citation: I. Benoy et al., VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR (VEGF) SERUM CONCENTRATIONS CHANGE ACCORDING TO THE PHASE OF THE MENSTRUAL-CYCLE, European journal of cancer, 34(8), 1998, pp. 1298-1299
Authors:
STEWART JM
MILLWARD MJ
ZALCBERG JR
Citation: Jm. Stewart et al., 2ND LINE TREATMENT OPTIONS IN ADVANCED COLORECTAL-CANCER, European journal of cancer, 34(7), 1998, pp. 953-955
Authors:
METZGER U
HONEGGER HP
Citation: U. Metzger et Hp. Honegger, RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) AS AN ADJUVANT FOR AUTOLOGOUS BLOOD TRANSFUSION, European journal of cancer, 34(7), 1998, pp. 956-957
Authors:
BENJAMIN RS
Citation: Rs. Benjamin, SHOULD PATIENTS WITH ADVANCED SARCOMAS BE TREATED WITH CHEMOTHERAPY -PRO, European journal of cancer, 34(7), 1998, pp. 958-962
Authors:
ROUESSE J
BOURGEOIS H
Citation: J. Rouesse et H. Bourgeois, SHOULD PATIENTS WITH ADVANCED SARCOMAS BE TREATED WITH CHEMOTHERAPY -CONTRA, European journal of cancer, 34(7), 1998, pp. 962-964